Yasushi Togo

703 total citations
24 papers, 526 citations indexed

About

Yasushi Togo is a scholar working on Epidemiology, Immunology and Molecular Biology. According to data from OpenAlex, Yasushi Togo has authored 24 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 5 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Yasushi Togo's work include Influenza Virus Research Studies (13 papers), Respiratory viral infections research (9 papers) and Virology and Viral Diseases (3 papers). Yasushi Togo is often cited by papers focused on Influenza Virus Research Studies (13 papers), Respiratory viral infections research (9 papers) and Virology and Viral Diseases (3 papers). Yasushi Togo collaborates with scholars based in United States and Japan. Yasushi Togo's co-authors include Richard B. Hornick, Eric M. Fine, Stanley Music, Robert H. Waldman, G. G. Heiner, A. T. Dawkins, J. John Mann, J. A. Kasel, Henry N. Wagner and Yasuo Sakakura and has published in prestigious journals such as Nature, New England Journal of Medicine and JAMA.

In The Last Decade

Yasushi Togo

24 papers receiving 418 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yasushi Togo United States 12 342 87 85 54 45 24 526
Y. Togo United States 9 235 0.7× 57 0.7× 82 1.0× 22 0.4× 39 0.9× 12 373
Elias G. Chalhub United States 11 306 0.9× 79 0.9× 97 1.1× 41 0.8× 63 1.4× 14 463
Whaijen Soo United States 5 376 1.1× 42 0.5× 119 1.4× 17 0.3× 74 1.6× 7 496
A.A. Poltera Switzerland 15 292 0.9× 49 0.6× 92 1.1× 10 0.2× 52 1.2× 38 722
S Z Wilson United States 12 299 0.9× 62 0.7× 169 2.0× 119 2.2× 65 1.4× 17 468
Gregg Y. Lipschik United States 12 474 1.4× 34 0.4× 257 3.0× 83 1.5× 74 1.6× 21 620
Ellen C. Cooper United States 5 188 0.5× 34 0.4× 108 1.3× 49 0.9× 25 0.6× 6 305
Brian Dickson United States 10 132 0.4× 48 0.6× 61 0.7× 22 0.4× 56 1.2× 22 588
P. J. Swart Netherlands 9 216 0.6× 60 0.7× 210 2.5× 25 0.5× 112 2.5× 19 600
P. White United States 9 236 0.7× 85 1.0× 68 0.8× 122 2.3× 214 4.8× 11 624

Countries citing papers authored by Yasushi Togo

Since Specialization
Citations

This map shows the geographic impact of Yasushi Togo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasushi Togo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasushi Togo more than expected).

Fields of papers citing papers by Yasushi Togo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasushi Togo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasushi Togo. The network helps show where Yasushi Togo may publish in the future.

Co-authorship network of co-authors of Yasushi Togo

This figure shows the co-authorship network connecting the top 25 collaborators of Yasushi Togo. A scholar is included among the top collaborators of Yasushi Togo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasushi Togo. Yasushi Togo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ohwada, Susumu, Tetsushi Ogawa, Fujio Makita, et al.. (2006). Beneficial effects of protein-bound polysaccharide K plus tegafur/uracil in patients with stage II or III colorectal cancer: Analysis of immunological parameters. Oncology Reports. 15(4). 861–8. 26 indexed citations
2.
Hoshino, Yoichi, et al.. (2005). Sacral Arachnoid Cyst Associated with Marfan Syndrome. Internal Medicine. 44(3). 271–273. 11 indexed citations
3.
FUKUMI, HIDEO, Mikio Kimura, Shunichi Kato, et al.. (1984). Clinical Report on Safety and Antigenicity of 23-valent Pneumococcal Polysaccharide Vaccine. Kansenshogaku zasshi. 58(6). 495–511. 1 indexed citations
4.
Miller, Louis W., Yasushi Togo, & Richard B. Hornick. (1977). Clinical and serologic effects of live attenuated serum inhibitor‐resistant influenza B vaccine in seronegative adults. Journal of Medical Virology. 1(3). 193–199. 4 indexed citations
5.
Togo, Yasushi, et al.. (1977). Clinical evaluation of prophylactic intranasal 1-phenyl-3-(4-phenyl-2-thiazolyl) guanidine (CL 88,277) medication against rhinovirus 44 challenge. Medical Microbiology and Immunology. 163(1). 37–44. 6 indexed citations
6.
Miller, Louis W., et al.. (1975). ALICE STRAIN LIVE ATTENUATED INFLUENZA (H3N2) VACCINE IN AN ELDERLY POPULATION. American Journal of Epidemiology. 101(4). 340–346. 11 indexed citations
7.
Togo, Yasushi, et al.. (1974). Evaluation of Isoprinosine in Experimental Human Rhinovirus Infection. Antimicrobial Agents and Chemotherapy. 5(4). 403–408. 23 indexed citations
8.
Levine, Myron M., Yasushi Togo, & Ellen R. Wald. (1974). PRACTICABILITY OF INFLUENZA SURVEILLANCE BY VIRUS CULTURE OF CHILDREN. American Journal of Epidemiology. 100(4). 272–276. 5 indexed citations
9.
Wald, Ellen R., Lê Thị Phượng, & Yasushi Togo. (1973). Concomitant varicella and staphylococcal scalded skin syndrome. The Journal of Pediatrics. 83(6). 1017–1019. 8 indexed citations
10.
Togo, Yasushi, et al.. (1973). Low-Temperature-Adapted Influenza A2/AA/6/60 Virus Vaccine in Man. Infection and Immunity. 7(1). 119–122. 17 indexed citations
11.
Togo, Yasushi. (1973). In Vitro Effect of Virazole Against Influenza Viruses. Antimicrobial Agents and Chemotherapy. 4(6). 641–642. 12 indexed citations
12.
Music, Stanley, Eric M. Fine, & Yasushi Togo. (1971). Zoster-like Disease in the Newborn Due to Herpes-Simplex Virus. New England Journal of Medicine. 284(1). 24–26. 37 indexed citations
13.
Hornick, Richard B., et al.. (1970). Evaluation of Amantodine Hydrochloride in the Treatment of A2 influenzal Disease. Annals of the New York Academy of Sciences. 173(1). 10–19. 11 indexed citations
14.
Togo, Yasushi. (1970). Evaluation of Therapeutic Efficacy of Amantadine in Patients With Naturally Occurring A2 Influenza. JAMA. 211(7). 1149–1149. 41 indexed citations
15.
Hornick, Richard B., et al.. (1969). Evaluation of amantadine hydrochloride in the treatment of A2 influenzal disease.. PubMed. 41(3). 671–6. 20 indexed citations
16.
Waldman, Robert H., J. A. Kasel, Yasushi Togo, et al.. (1968). Influenza Antibody in Human Respiratory Secretions after Subcutaneous or Respiratory Immunization with Inactivated Virus. Nature. 218(5141). 594–595. 83 indexed citations
17.
Togo, Yasushi. (1968). Studies on Induced Influenza in Man. JAMA. 203(13). 1089–1089. 96 indexed citations
18.
Togo, Yasushi. (1964). HEMAGGLUTINATION—INHIBITION TEST IN THE STUDY OF MEASLES IMMUNITY1. American Journal of Epidemiology. 79(3). 250–259. 3 indexed citations
19.
Togo, Yasushi, et al.. (1962). Fatal neonatal infection due to Coxsackie B2 virus. The Journal of Pediatrics. 61(6). 911–918. 16 indexed citations
20.
McCrumb, Fred R., et al.. (1962). Clinical Trials with Living Attenuated Measles Virus Vaccines. American Journal of Public Health and the Nations Health. 52(Suppl_2). 11–15. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026